Treatment decision making and psychosocial outcomes associated with rapid genetic testing for BRCA1 and BRCA2 in women newly diagnosed with breast cancer

被引：2
|
作者：
Metcalfe, Kelly A.
Narod, Steven
Eisen, Andrea
Lerner-Ellis, Jordan
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Womens Coll Res Inst, Toronto, ON, Canada
[3] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[4] Mt Sinai Hosp, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.1586
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1586
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Outcomes associated with rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis.
    Metcalfe, Kelly A.
    Poll, Aletta
    Eisen, Andrea
    Lerner-Ellis, Jordan
    Narod, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients
    Schwartz, MD
    Lerman, C
    Brogan, B
    Peshkin, BN
    Halbert, CH
    DeMarco, T
    Lawrence, W
    Main, D
    Finch, C
    Magnant, C
    Pennanen, M
    Tsangaris, T
    Willey, S
    Isaacs, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) : 1823 - 1829
  • [3] Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients
    Schwartz, MD
    Lerman, C
    Brogan, B
    Peshkin, BN
    Isaacs, C
    DeMarco, T
    Halbert, CH
    Pennanen, M
    Finch, C
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 1003 - 1007
  • [4] Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning
    Kelly A. Metcalfe
    Andrea Eisen
    Frances Wright
    Aletta Poll
    Alexandra Candib
    David McCready
    Tulin Cil
    Susan Armel
    Yael Silberman
    Sarah Brennenstuhl
    Steven A. Narod
    Breast Cancer Research and Treatment, 2022, 191 : 631 - 641
  • [5] Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning
    Metcalfe, Kelly A.
    Eisen, Andrea
    Wright, Frances
    Poll, Aletta
    Candib, Alexandra
    McCready, David
    Cil, Tulin
    Armel, Susan
    Silberman, Yael
    Brennenstuhl, Sarah
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (03) : 631 - 641
  • [6] Predictors of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz, M
    Lerman, C
    Brogan, B
    Peshkin, B
    Isaacs, C
    DeMarco, T
    Pennanen, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1328S - 1329S
  • [7] Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer
    Daniels, Molly S.
    Urbauer, Diana L.
    Stanley, Jennifer L.
    Johnson, Kristin G.
    Lu, Karen H.
    GENETICS IN MEDICINE, 2009, 11 (09) : 624 - 628
  • [8] BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
    Rosenberg, Shoshana M.
    Ruddy, Kathryn J.
    Tamimi, Rulla M.
    Gelber, Shari
    Schapira, Lidia
    Come, Steven
    Borges, Virginia F.
    Larsen, Bryce
    Garber, Judy E.
    Partridge, Ann H.
    JAMA ONCOLOGY, 2016, 2 (06) : 730 - 736
  • [9] Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation
    Metcalfe, K. A.
    Poll, A.
    O'Connor, A.
    Gershman, S.
    Armel, S.
    Finch, A.
    Demsky, R.
    Rosen, B.
    Narod, S. A.
    CLINICAL GENETICS, 2007, 72 (03) : 208 - 217
  • [10] Genetic testing for women previously diagnosed with breast/ovarian cancer:: Examining the impact of BRCA1 and BRCA2 mutation searching
    Hallowell, N
    Foster, C
    Ardern-Jones, A
    Eeles, R
    Murday, V
    Watson, M
    GENETIC TESTING, 2002, 6 (02): : 79 - 87
12345